Application

18019270 · CRYSTALINE FORMS OF AN O-GLYCOPROTEIN-2-ACETAMIDO-2-DEOXY-3-D-GLUCOPYRANOSIDASE INHIBITOR

Filed 2023-02-02 · Abandoned The official file ↗ · Art unit 1626 · Examiner Meghan Christine Heasley Typical · CPC C07D 417/14 · BIOGEN MA INC. · McCarter & English, LLP / Biogen MA

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

28.7 mo

to disposition 42.5 mo

Statutes raised

112

2 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.